Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

JFM · Predicate Candidate Screening

11 FDA 510(k) clearances under this product code; the 50 most recent screened below.

52 daysmedian FDA review time
181 days90th percentile
11clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K170065ADVIA® Chemistry Total Bilirubin_2 (TBIL_2)Siemens Healthcare Diagnostics, Inc.2017-03-09591
K152343Direct BilirubinRandox Laboratories Limited2016-02-161810
K152344Total BilirubinRandox Laboratories Limited2016-01-281621
K063845ADVIA CHEMISTRY TOTAL BILIRUBIN_2Bayer Healthcare, LLC2007-12-073450
K053132WAKO DIRECT BILIRUBIN V, MODELS 996-23591, 412-22901, 992-23Wako Chemicals USA, Inc.2005-12-30520
K053131WAKO TOTAL BILIRUBIN V, MODELS 410-22701, 998-23291, 416-228Wako Chemicals USA, Inc.2005-12-30520
K053090DRI-STAT ENZYMATIC BILIRUBIN REAGENT, SYNCHRON SYSTEMS BILIRBeckman Coulter, Inc.2005-12-16440
K050266DIRECT BILIRUBIN LIQUICOLOR AND TOTAL BILIRUBIN LIQUICOLORStanbio Laboratory2005-06-301460
K970985WAKO TOTAL BILIRUBIN VWako Chemicals USA, Inc.1997-04-21340
K904660ENZYMATIC BILIRUBIN (TOTAL), CATALOGUE NO. 202-14Diagnostic Chemicals, Ltd. (Usa)1990-11-20360
K843174DRI-STAT ENZYMATIC BILIRUBIN TEST KITBeckman Instruments, Inc.1984-09-14320

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams: atlasbyauro.com/fda